CollPlant Biotechnologies annual depreciation and amortization
2017
2018
2019
2020
2021
2022
2023
2024
2025
CollPlant Biotechnologies Depreciation & Amortization Growth & History (CLGN)
CollPlant Biotechnologies's depreciation and amortization was $912,000 for fiscal 2025.
View full CollPlant Biotechnologies company overviewCollPlant Biotechnologies annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $912,000 | −$126,000 | −12.14% |
| 2024 | 2024-12-31 | $1.0M | −$64,000 | −5.81% |
| 2023 | 2023-12-31 | $1.1M | $26,000 | +2.42% |
| 2022 | 2022-12-31 | $1.1M | $303,000 | +39.20% |
| 2021 | 2021-12-31 | $773,000 | $113,000 | +17.12% |
| 2020 | 2020-12-31 | $660,000 | $121,000 | +22.45% |
| 2019 | 2019-12-31 | $539,000 | $197,000 | +57.60% |
| 2018 | 2018-12-31 | $342,000 | $112,000 | +48.70% |
| 2017 | 2017-12-31 | $230,000 | — | — |
CollPlant Biotechnologies quarterly depreciation and amortization
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $210,000 | −$34,000 | −13.93% |
| Q4 2025 | 2025-12-31 | $216,000 | — | — |
| Q3 2025 | 2025-09-30 | $223,000 | — | — |
| Q2 2025 | 2025-06-30 | $229,000 | — | — |
| Q1 2025 | 2025-03-31 | $244,000 | — | — |
CollPlant Biotechnologies depreciation and amortization trends
Over the last five fiscal years, CollPlant Biotechnologies's depreciation and amortization increased from $660,000 to $912,000, a change of $252,000. The latest reported quarter, Q1 2026, shows $210,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CollPlant Biotechnologies source filings ↗